[Ip-health] Chilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents.

ED SILVERMAN ed.silverman at comcast.net
Thu Jan 26 07:58:22 PST 2017


looks like the resolution was passed on dec 17, yes?

https://www.camara.cl/trabajamos/presolucion_detalle.aspx?prmID=4692

> On January 25, 2017 at 5:03 PM "Andrew S. Goldman" <andrew.goldman at keionline.org> wrote:
>
>
> An unofficial English translation of the quoted Spanish section of the
> Chilean resolution (I have added this to the blog):
>
> 1.-To the Ministry of Health:
> A) To incorporate and use the compulsory licensing mechanism provided for
> in article 51 numeral 2) of the industrial property law, especially for
> reasons of Public Health and non-commercial government use, to facilitate
> its acquisition at competitive prices both by the public services as well
> as by the private health services and the population that requires it; And
> ultimately guarantee their access.
>
> B) To elaborate administrative directives, circulars and protocols or
> procedures within the health sector for the selection and prioritization of
> products or procedures related to medicines subject to patents that must be
> considered for purposes of compulsory licensing requirements based on
> public health reasons and non-commercial government use.
>
> 2.- The Ministry of Economy, Development and Tourism
> A) To review and update the regulation of said article 51 of the industrial
> property law 19039 for the purpose of developing and complementing what is
> established in said legal provision, granting a greater degree of fluidity
> and legal certainty for its application by the competent bodies and
> Individuals.
>
> B) To develop and publish administrative guidelines for the granting of
> such licenses consistent with the objective of protection of the right to
> health and life, including parameters and other criteria for the purposes
> of determining remuneration and other conditions for the granting of the
> said licenses.
>
>
> --
> Andrew S. Goldman
> Counsel, Policy and Legal Affairs
> Knowledge Ecology International
> andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
> tel.: +1.202.332.2670
> www.keionline.org
>
> 2017-01-25 14:00 GMT-05:00 Andrew S. Goldman <andrew.goldman at keionline.org>:
>
> > Chilean Cámara de Diputados votes overwhelmingly to advance compulsory
> > licensing of drug patents.
> >
> > http://keionline.org/node/2716
> >
> > The Cámara de Diputados of the Chilean Congress reportedly voted today
> > 67-32 in favor of Resolution 798, put forward by Giorgio Jackson and six
> > other members. The resolution requests that the President of Chile, through
> > the Ministry of Health, use and create protocols for the use of compulsory
> > licenses for pharmaceutical patents as a public policy tool to combat high
> > drug prices and increase access, and, through the Ministry of Economic
> > Development and Tourism, update regulations for the expedited processing of
> > compulsory licenses. The text of the specific requests is below (in
> > Spanish).
> >
> > The resolution seems to have been buoyed by the recent report by the
> > United Nations Secretary-General's High-Level Panel on Access to Medicines,
> > which is cited in the explanatory text.
> >
> > The vote is a remarkable and welcome expression of political support by
> > federal lawmakers for the use of compulsory licenses. The members of the
> > Chilean Congress are pressing to put the patent monopoly at risk, rather
> > than the patient. Giorgio Jackson and the other members of Congress who
> > voted overwhelmingly in favor deserve support and appreciation for their
> > leadership on behalf of patient interests and illustrating that to protect
> > human rights, political action is needed.
> >
> > Resolución No. 798, Sesión 120, Jan 25 2017
> > [Snip]
> > ACORDAMOS
> >
> > Solicitar, por intermedio de S.E. la Presidenta de la República:
> >
> > 1.-Al Ministerio de Salud:
> > a) Que incorpore y utilice de oficio el mecanismo de las licencias
> > obligatorias que contempla el artículo 51 numeral 2) de la ley propiedad
> > industrial, en especial por razones de Salud Pública y uso de gobierno no
> > comercial, para facilitar su adquisición a precios competitivos tanto por
> > parte de los servicios públicos como por los servicios de salud privados y
> > la población que lo requiera; y en definitiva garantizar su acceso.
> >
> > b) Que elabore las directrices administrativas, circulares y protocolos o
> > procedimientos dentor del sector salud para la selección y priorización de
> > los productos o procedimientos referidos a medicamentos sujetos a patentes
> > que deban ser considerados para efectos de requerimientos de licencias
> > obligatorias atendiendo razones de salud pública y usos de gobierno no
> > comerciales.
> >
> > 2.- Al Ministerio de Economía, Fomento y Turismo
> > a)Que revise y actualice la reglamentación del referido artículo 51 de la
> > ley de propiedad industrial 19039 para efectos de desarollar y complementar
> > lo establecido en el referido precepto legal otorgando un mayor grado de
> > fluidez y certeza jurídica para su aplicación por los órganos competentes y
> > los particulares.
> >
> > b) Que elabore y publique directrices administrativas para el otorgamiento
> > de dichas licencias que sean consistentes con el objectivo de protección
> > del derecho de la salud y la vida, incluyendo parámetros y otros criterios
> > para efectos de la determinación de la remuneración y otras condiciones
> > para el otorgamiento de las referidas licencias.
> >
> > --
> > Andrew S. Goldman
> > Counsel, Policy and Legal Affairs
> > Knowledge Ecology International
> > andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
> > tel.: +1.202.332.2670 <(202)%20332-2670>
> > www.keionline.org
> >
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org



More information about the Ip-health mailing list